CBLL compared with SION: revenue, margins and what each company keeps, and the suppliers and customers both name

CBLLCeribell, Inc.

Mkt capRevenueRevenue

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CBLLCeribell, Inc.

SIONSionna Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CBLL

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±13.1%▲+10.41%×0.79

May 12 '26±13.1%▼−16.50%×1.26

Q1 FY26±13.4%▼−4.77%×0.36

Q3 FY25±25.4%▲+7.88%×0.31

SION

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+4.80%—

May 12 '26±10.9%▼−10.90%×1.00

= impliedCBLL realized, solidSION realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedSource: market data

Q1 FY26

—

▼−7.17%

—

Nov 5 '25—▼−1.57%—

CBLLCeribell, Inc.

28.27▲+4.85%· post 25.00· delayed

Mkt cap$1.0BRevenue$28MQ2 FY26Revenue$89MFY25

SIONSionna Therapeutics, Inc.

3.75▲+0.51%· post 3.66· delayed

After hoursNov 3 '26delayed

Mkt cap$168.4MRevenue—Revenue—

Compare

After hoursNov 3 '26delayed

CBLLCeribell, Inc.

SIONSionna Therapeutics, Inc.

28.27▲+4.85%post 25.00delayed

Price

3.75▲+0.51%post 3.66delayed

$1.0B

Mkt cap

$168.4M

Q2 FY26$28M

Revenue

—

FY25$89M

Revenue

—

CBLL28.27▲+4.85%vsSION3.75▲+0.51%After hoursNov 3 '26delayed